Deep Health AI

Why is Deep Health AI India Ltd falling/rising?

As of 01-Sep, Deep Health AI India Ltd's stock price is at 1.85, down 2.63%, reflecting significant underperformance with a year-to-date decline of 68.54% and ongoing financial struggles, including operating losses and weak sales growth. The stock is trading below all moving averages and has seen decreased investor participation.

As of 01-Sep, Deep Health AI India Ltd's stock price is falling, currently at 1.85, reflecting a decrease of 0.05 or 2.63%. This decline is part of a broader trend, as the stock has underperformed significantly over various time periods, including a 1-week drop of 1.60% and a 1-month decline of 9.31%. Year-to-date, the stock has plummeted by 68.54%, while over the past year, it has generated a return of -57.08%. <BR><BR>The company's performance today indicates it has underperformed its sector by 0.81%, and it is trading below its moving averages across all time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Additionally, there has been a decrease in investor participation, with delivery volume falling by 1.49% compared to the 5-day average.<BR><BR>Despite a high dividend yield of 5.26%, the company is facing significant challenges, including operating losses and weak long-term fundamental strength. The net sales growth over the last five years has been only 7.19%, and the company's ability to service its debt is weak, as indicated by a poor EBIT to Interest ratio of 0.29. Furthermore, the company's recent financial results show a substantial decline in profitability, with a PAT of Rs -2.15 crore, which has fallen by 3683.3%. <BR><BR>Overall, the consistent underperformance against benchmarks and the company's financial struggles contribute to the ongoing decline in its stock price.

Who are in the management team of Deep Health AI?

The management team of Deep Health AI includes Ganpat Lal Nyati (Executive Director), Sonali Laddha (CEO), and several non-executive directors: Narendra Shrimali, Ashish Jain, and Vinod Mandowara, along with Prashant Tali (Company Secretary) and Kaushal Jain (Additional Director).

The management team of Deep Health AI includes the following individuals:<BR><BR>1. **Ganpat Lal Nyati** - Executive Director & Wholetime Director<BR>2. **Sonali Laddha** - Executive Director & CEO<BR>3. **Narendra Shrimali** - Non-Executive & Non-Independent Director<BR>4. **Ashish Jain** - Non-Executive & Non-Independent Director<BR>5. **Vinod Mandowara** - Non-Executive & Non-Independent Director<BR>6. **Prashant Tali** - Company Secretary & Compliance Officer<BR>7. **Kaushal Jain** - Additional Director<BR><BR>If you have any more questions about Deep Health AI or its operations, feel free to ask!

What does Deep Health AI do?

Deep Health AI India Ltd manufactures and wholesales gold set jewellery with diamonds and provides consultancy services to the Pharmaceutical Industry. As of June 2026, it reported net sales of 0 Cr and a net profit of -2 Cr, with a market cap of INR 27 Cr.

Overview:<BR>Deep Health AI India Ltd operates in the Gems, Jewellery and Watches industry, focusing on the manufacture and wholesale of gold set jewellery with diamonds, as well as providing consultancy services to the Pharmaceutical Industry.<BR><BR>History:<BR>Deep Health AI India Ltd was established in 1994. The company has recently expanded its operations to include consultancy services for the Pharmaceutical Industry. The latest quarterly results reported are for June 2026.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 0 Cr (Quarterly Results - Jun 2026) <BR>Most recent Net Profit: -2 Cr (Quarterly Results - Jun 2026) <BR>Market-cap value: INR 27 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 6.00 <BR>Industry P/E: 49 <BR>Dividend Yield: 5.38% <BR>Debt-Equity: -0.17 <BR>Return on Equity: 13.41% <BR>Price-to-Book: 0.52 <BR><BR>Contact Details:<BR>Address: 101 1st Floor Hemu Plaza, D J Road Vile Parle (W) Mumbai Maharashtra : 400056 <BR>Tel: 91-22-26174321/65043314 <BR>Website: http://www.deepdiamondindialimited.com

Who are the peers of the Deep Health AI?

Deep Health AI's peers include Rajnish Retail, Shoora Designs, Koura Fine Diamo, and others, with varying management risks and growth ratings. Deep Health AI has a 1-year return of -57.96%, better than Rajnish Retail's -67.47% but worse than Koura Fine Diamo's 35.61%.

Peers: The peers of Deep Health AI are Rajnish Retail, Shoora Designs, Koura Fine Diamo, Kanani Industrie, U. H. Zaveri, Orosil Smiths, Goenka Diamond, Kenvi Jewels, Darshan Orna.<BR><BR>Quality Snapshot: Excellent management risk is observed at Rajnish Retail and Orosil Smiths, while Average management risk is found at Deep Health AI. Below Average management risk is noted at Shoora Designs, Koura Fine Diamo, Kanani Industrie, U. H. Zaveri, Goenka Diamond, Kenvi Jewels, Darshan Orna, and the rest. Growth is rated as Good for Koura Fine Diamo and Deep Health AI, while Below Average growth is seen at Rajnish Retail, Shoora Designs, Kanani Industrie, U. H. Zaveri, Goenka Diamond, and the rest. Average growth is noted at Kenvi Jewels and Darshan Orna. Capital Structure is rated as Good for Rajnish Retail, Koura Fine Diamo, and Deep Health AI, while Below Average capital structure is found at Kanani Industrie, U. H. Zaveri, Orosil Smiths, Goenka Diamond, Kenvi Jewels, and the rest.<BR><BR>Return Snapshot: Koura Fine Diamo has the highest 1-year return at 35.61%, while Rajnish Retail has the lowest at -67.47%. Deep Health AI's 1-year return of -57.96% is better than Rajnish Retail's but worse than Koura Fine Diamo's. Additionally, the six-month returns are negative for Rajnish Retail, Kanani Industrie, U. H. Zaveri, Goenka Diamond, Kenvi Jewels, Darshan Orna, and Shubhlaxmi Jewel.

How big is Deep Health AI?

As of 31st August, Deep Health AI India Ltd has a market capitalization of 27.00 Cr, with Net Sales of 4.55 Cr and a Net Profit loss of 1.09 Cr over the latest four quarters. Shareholder's Funds are 22.36 Cr, and Total Assets are 23.96 Cr as of March 2025.

As of 31st August, Deep Health AI India Ltd has a market capitalization of 27.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 4.55 Cr. However, it experienced a loss of 1.09 Cr in Net Profit during the same period.<BR><BR>The latest annual reporting period for the balance sheet is March 2025. Shareholder's Funds stood at 22.36 Cr, while Total Assets were valued at 23.96 Cr.

Which are the latest news on Deep Health AI?

Should I buy, sell or hold Deep Health AI India Ltd?

Are Deep Health AI India Ltd latest results good or bad?

Deep Health AI India Ltd's latest results are concerning, showing a net loss of ₹4.51 crores in Q4 FY26, a 1,388.57% decline year-on-year, and a revenue drop of 44.44%. The company faces significant operational and financial challenges, reflected in a 50.80% decline in stock value over the past year.

The latest results for Deep Health AI India Ltd are concerning and indicate a significant decline in performance. In the fourth quarter of FY26, the company reported a net loss of ₹4.51 crores, which is a staggering 1,388.57% decrease compared to the same quarter last year. This marks a drastic shift from profitability to substantial losses, highlighting severe operational challenges.<BR><BR>Revenue for the same quarter was only ₹0.25 crores, reflecting a 44.44% decline year-on-year and a 50% drop from the previous quarter. This revenue collapse suggests that the company is struggling to establish a sustainable business model, especially as it attempts to diversify into pharmaceutical consultancy services.<BR><BR>Additionally, the company's profit before tax was negative ₹5.54 crores, indicating significant one-off charges or exceptional items that have not been detailed. The operational metrics reveal a company in distress, with an operating margin of just 20% on minimal revenue, and a PAT margin of -1,804%.<BR><BR>The stock has also suffered severely, declining 50.80% over the past year, underperforming significantly compared to broader market indices. Given these factors, the overall assessment of Deep Health AI India Ltd's latest results is decidedly negative, suggesting that the company is facing critical operational and financial challenges.

When is the next results date for Deep Health AI India Ltd?

The next results date for Deep Health AI India Ltd is 13 August 2026.

The next results date for Deep Health AI India Ltd is scheduled for 13 August 2026.

How has been the historical performance of Deep Diamond?

Deep Diamond has experienced a significant decline in net sales over three years, dropping from 7.67 Cr in Mar'23 to 1.26 Cr in Mar'25, while improving profitability metrics such as operating profit and profit before tax in the latest year. Total liabilities and assets increased slightly, and shareholder's funds strengthened, indicating a challenging environment with some recovery in profitability.

Answer:<BR>The historical performance of Deep Diamond shows a significant decline in net sales over the past three years, dropping from 7.67 Cr in Mar'23 to 2.56 Cr in Mar'24, and further down to 1.26 Cr in Mar'25. Total operating income followed a similar trend, decreasing from 7.67 Cr in Mar'23 to 2.56 Cr in Mar'24, and then to 1.26 Cr in Mar'25. Despite the decline in sales, the company managed to improve its operating profit (PBDIT) from 1.85 Cr in Mar'23 to 0.84 Cr in Mar'24, and further to 1.20 Cr in Mar'25. Profit before tax also increased from 1.73 Cr in Mar'23 to 0.57 Cr in Mar'24, reaching 1.09 Cr in Mar'25. The profit after tax showed a similar pattern, with values of 1.26 Cr, 0.42 Cr, and 0.86 Cr for the respective years. The earnings per share (EPS) decreased from 0.26 in Mar'23 to 0.08 in Mar'24, but increased to 0.17 in Mar'25. <BR><BR>In terms of balance sheet results, total liabilities rose slightly from 23.06 Cr in Mar'24 to 23.96 Cr in Mar'25, while total assets also increased from 23.06 Cr to 23.96 Cr in the same period. Shareholder's funds improved from 20.42 Cr in Mar'24 to 22.36 Cr in Mar'25, indicating a strengthening equity position. The cash flow from operating activities remained stagnant at 0.00 Cr in Mar'25, while it was negative at -5.00 Cr in Mar'24. The closing cash and cash equivalents remained unchanged at 3.00 Cr for both years. Overall, Deep Diamond's financial performance reflects a challenging environment with declining sales but some recovery in profitability metrics in the latest year.

Is Deep Diamond overvalued or undervalued?

As of May 30, 2025, Deep Diamond is considered very expensive and overvalued, with a PE ratio of 15.01, an EV to EBIT of 12.30, and a disappointing year-to-date return of -30.99%, especially compared to its peers and the Sensex's positive return of 5.61%.

As of 30 May 2025, the valuation grade for Deep Diamond has moved from risky to very expensive. This indicates a significant shift in the perception of the company's value, suggesting that it is currently overvalued. The key ratios reflect this sentiment, with a PE ratio of 15.01, an EV to EBIT of 12.30, and a ROE of 3.94%. <BR><BR>In comparison to its peers, Deep Diamond's valuation stands out unfavorably; for instance, Titan Company has a PE ratio of 94.61 and Kalyan Jewellers at 81.3, both indicating a more robust market position despite their higher valuations. The company's recent stock performance has also been underwhelming, with a year-to-date return of -30.99%, contrasting sharply with the Sensex's positive return of 5.61% over the same period. Overall, Deep Diamond appears to be overvalued in the current market context.

What is the technical trend for Deep Diamond?

As of June 5, 2025, Deep Diamond's trend is mildly bearish, with daily moving averages indicating a bearish outlook, while weekly indicators show mixed signals, leading to an overall weak trend.

As of 5 June 2025, the technical trend for Deep Diamond has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by the daily moving averages indicating a mildly bearish outlook, while the weekly MACD shows a mildly bullish signal, contrasting with the monthly MACD which remains bearish. The Bollinger Bands are bearish on both weekly and monthly time frames, and the KST indicates a mildly bullish trend weekly but mildly bearish monthly. Overall, the lack of strong signals from the RSI and Dow Theory suggests a weak trend in both weekly and monthly perspectives.

Who are the top shareholders of the Deep Diamond?

The top shareholders of Deep Diamond are primarily individual investors, holding 89.27% of shares. Notable shareholders include Bhavishya Ecommerce Private Limited at 3.55%, and Prakash Rikhabchand Solanki, the main promoter, with 0.02%.

The top shareholders of Deep Diamond include individual investors, who hold a significant 89.27% of the shares. Among the notable public shareholders, Bhavishya Ecommerce Private Limited holds 3.55%. The promoter with the highest holding is Prakash Rikhabchand Solanki, with a stake of 0.02%. Additionally, there is one Foreign Institutional Investor (FII) that holds 1.04% of the shares. There are no pledged promoter holdings or mutual fund schemes involved in the shareholding structure.

Has Deep Diamond declared dividend?

No Dividend History Available